KE4-25467-33065
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 775 / TX
- Registered
- 2022-01-18
- Relationship
- Child or adolescent in my care
- Guardian
- 2LB-11254-64480
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-18
Registered in v-safe
-
2022-01-18
Dose 1 — Pfizer-BioNTech
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-22
-
2022-01-25
Survey response — day 7, dose 1, dependentMedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose, congestion like a cold.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-01
-
2022-02-08
Dose 2 — Pfizer-BioNTech
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-12
- 2022-02-13
- 2022-02-15
- 2022-02-22
- 2022-03-01
- 2022-03-08
- 2022-03-15
- 2022-03-22
- 2022-05-10
- 2022-08-09
- 2023-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-18 | Pfizer-BioNTech | No |
| 2 | 2022-02-08 | Pfizer-BioNTech | No |
Free text
Release 11 — day 7, dose 1, dependent
Systemic reaction (other): Runny nose, congestion like a cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release